Best for skin and anti-aging
These four compounds appear in skin and anti-aging conversations, but their evidence records differ. Each entry lists its evidence level, regulatory context, and full compound page. This curation keeps topical cosmetic evidence separate from systemic anti-aging claims and does not provide dosing, treatment, or purchasing guidance.
GHK-Cu
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is frequently discussed in skin-repair and cosmetic-peptide literature. The record includes cellular and animal research, a small randomized topical study, and an ongoing topical-wound trial.
Evidence level: Limited human evidence
Regulatory status: The reviewed FDA record includes injectable GHK-Cu in a withdrawn-nomination table, not the active Category 2 table, and does not establish an approved GHK-Cu drug use. Topical cosmetic, medical, and injectable claims require different regulatory analysis.
A 2015 author-linked review describes cellular, animal, and cosmetic research. Thirteen participants completed a randomized topical study that found no objective post-laser advantage despite higher patient satisfaction. These records do not support systemic anti-aging claims.
Author-linked review of cellular, animal, skin-penetration, and cosmetic research involving GHK and GHK-Cu. The authors were affiliated with Skin Biology Research and Development, so the review is useful for mapping hypotheses but is not independent clinical efficacy evidence.
pubmed-ghk-skin-regeneration-review-2015Randomized topical study with 13 completers after CO2 laser resurfacing. Objective erythema, wrinkle, and overall skin-quality outcomes did not differ between groups, while patient satisfaction was higher with the GHK-Cu regimen.
pubmed-ghkcu-postlaser-2006FDA risk page lists BPC-157: compounded BPC-157 may pose immunogenicity risk and peptide-related impurity concerns for certain routes of administration.
fda-bulk-risk-listArgireline (acetyl hexapeptide-8)
Argireline (Acetyl Hexapeptide-8) is a synthetic hexapeptide fragment of SNAP-25: one of the targets of botulinum toxin. Marketed as 'botox in a jar,' it is the most recognizable topical wrinkle-reduction peptide in consumer skincare and one of the few with a randomized controlled trial.
Evidence level: Peer reviewed
Regulatory status: Used in topical cosmetics, with no FDA drug approval for Argireline. Claims to treat disease or affect body structure or function can make a product a drug.
A randomized, placebo-controlled study (n=60) showed that topical 10% acetyl hexapeptide-8 applied twice daily for 4 weeks reduced peri-orbital wrinkle depth (Wang et al., Am J Clin Dermatol, 2013). The SNARE inhibition mechanism is proposed based on the peptide's relationship to SNAP-25 but clinical evidence for this mechanism in human skin is limited. Do not equate topical argireline to botulinum toxin injections, which have substantially stronger evidence.
Randomized, placebo-controlled four-week study of topical acetyl hexapeptide-8 in 60 Chinese participants. The small, short study reported subjective and skin-roughness outcomes and did not compare the product with botulinum toxin.
pubmed-argireline-clinical-2013The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study
pubmed-argireline-combination-2017Acetyl hexapeptide-8 - Wikipedia
wikipedia-argirelineMatrixyl (Palmitoyl Pentapeptide-4)
Matrixyl (Palmitoyl Pentapeptide-4, formerly Palmitoyl Pentapeptide-3) is a matrikine peptide (Pal-KTTKS) and one of the most researched cosmetic peptides for collagen stimulation and wrinkle reduction. Originally launched by Sederma SAS in 2000, it has a 12-week double-blind placebo-controlled clinical trial supporting its use.
Evidence level: Peer reviewed
Regulatory status: Used in topical cosmetics, with no FDA drug approval for Matrixyl. Product classification depends on the claims made for it.
A 12-week double-blind, placebo-controlled, split-face RCT (n=93, Caucasian females aged 35-55) showed that topical 3 ppm pal-KTTKS provided significant improvement in fine lines and wrinkles vs. placebo (Robinson et al., Int J Cosmet Sci, 2005). In vitro studies demonstrate collagen neosynthesis, and permeation studies confirm the palmitoyl chain improves skin penetration. Evidence supports modest improvement: do not overstate as equivalent to prescription retinoids or procedures.
Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin
pubmed-palmitoyl-pentapeptide-clinical-2005Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)
pubmed-kttks-permeation-2014Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics
pubmed-palmitoyl-pentapeptide-cosmetics-2009Palmitoyl pentapeptide-4 - Wikipedia
wikipedia-matrixylEpitalon
Epitalon (Ala-Glu-Asp-Gly) is included as the telomere research entry: the most discussed peptide in longevity and anti-aging biology contexts. It represents the boundary between cosmetic skin peptides and systemic anti-aging claims, and requires the most conservative editorial framing.
Evidence level: Peer reviewed (single Group preclinical)
Regulatory status: Research peptide under FDA regulatory review. Scheduled for FDA Pharmacy Compounding Advisory Committee discussion in July 2026. Listed on the FDA bulk drug substances risk list for compounding. Not approved for any indication.
Studies from a single Russian research group (Khavinson et al.) report that Epitalon increases telomerase activity in human cells. This telomerase claim lacks independent Western replication. Online longevity content promotes Epitalon as an anti-aging peptide despite the absence of large-scale human clinical trials. Reviews note that geroprotective claims rest on preclinical data from limited research groups.
Studies by Khavinson and colleagues reporting that Epitalon (Ala-Glu-Asp-Gly) increases telomerase activity in human somatic cells. Research is primarily from a single Russian research group and lacks independent Western replication.
pubmed-epitalon-telomerase-khavinson-2003Reviews of Epitalon and related peptides in the context of aging biology, noting that telomerase and longevity claims rest on preclinical data from limited research groups without large-scale human clinical trials.
pubmed-epitalon-longevity-reviewFDA Pharmacy Compounding Advisory Committee meeting notice for July 23 to 24, 2026, scheduling peptide bulk substances for discussion.
fda-pcac-july-2026FDA risk page lists BPC-157: compounded BPC-157 may pose immunogenicity risk and peptide-related impurity concerns for certain routes of administration.
fda-bulk-risk-listThis page is an editorial curation, not a purchasing recommendation or treatment protocol. The FDA source linked for GHK-Cu addresses injectable compounding risk in a withdrawn-nomination table, while the reviewed GHK-Cu human record is topical. GHK-Cu is not in the page's active Category 2 table. Evidence across the page ranges from small cosmetic studies to preclinical findings.
Source records are stored in the repo and linked from this page.
Author-linked review of cellular, animal, skin-penetration, and cosmetic research involving GHK and GHK-Cu. The authors were affiliated with Skin Biology Research and Development, so the review is useful for mapping hypotheses but is not independent clinical efficacy evidence.
pubmed-ghk-skin-regeneration-review-2015Randomized topical study with 13 completers after CO2 laser resurfacing. Objective erythema, wrinkle, and overall skin-quality outcomes did not differ between groups, while patient satisfaction was higher with the GHK-Cu regimen.
pubmed-ghkcu-postlaser-2006FDA risk page lists BPC-157: compounded BPC-157 may pose immunogenicity risk and peptide-related impurity concerns for certain routes of administration.
fda-bulk-risk-listRandomized, placebo-controlled four-week study of topical acetyl hexapeptide-8 in 60 Chinese participants. The small, short study reported subjective and skin-roughness outcomes and did not compare the product with botulinum toxin.
pubmed-argireline-clinical-2013The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study
pubmed-argireline-combination-2017Acetyl hexapeptide-8 - Wikipedia
wikipedia-argirelineTopical palmitoyl pentapeptide provides improvement in photoaged human facial skin
pubmed-palmitoyl-pentapeptide-clinical-2005Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)
pubmed-kttks-permeation-2014Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics
pubmed-palmitoyl-pentapeptide-cosmetics-2009Palmitoyl pentapeptide-4 - Wikipedia
wikipedia-matrixylStudies by Khavinson and colleagues reporting that Epitalon (Ala-Glu-Asp-Gly) increases telomerase activity in human somatic cells. Research is primarily from a single Russian research group and lacks independent Western replication.
pubmed-epitalon-telomerase-khavinson-2003Reviews of Epitalon and related peptides in the context of aging biology, noting that telomerase and longevity claims rest on preclinical data from limited research groups without large-scale human clinical trials.
pubmed-epitalon-longevity-reviewFDA Pharmacy Compounding Advisory Committee meeting notice for July 23 to 24, 2026, scheduling peptide bulk substances for discussion.
fda-pcac-july-2026